IMMEDIATE RELEASE 4-METHYL-3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]-N-[5-(4-METHYL- 1H-IMIDAZOL-1-YL)-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE FORMULATION - Patent 2779995

(19)

(11)

EP 2 779 995 A1

(12)

(43)	Date of publication:
	24.09.2014 Bulletin 2014/39

(21)	Application number: 12798500.0

(22)	Date of filing: 12.11.2012

(51)

International Patent Classification (IPC):

A61K 9/00^(2006.01)
A61K 9/28^(2006.01)

A61K 9/20^(2006.01)

(86)	International application number:
	PCT/US2012/064610

(87)	International publication number:
	WO 2013/074432 (23.05.2013 Gazette 2013/21)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME

(30)

Priority:

14.11.2011 US 201161559281 P

(71)	Applicant: Novartis AG
	4056 Basel (CH)

(72)	Inventors:
	BHARDWAJ, Upkar East Hanover New Jersey 07936-1080 (US) BORDAWEKAR, Mangesh Sadashiv East Hanover New Jersey 07936-1080 (US) COMFORT, Ann Reese East Hanover New Jersey 07936-1080 (US) LI, Ping East Hanover New Jersey 07936-1080 (US) LI, Shoufeng East Hanover New Jersey 07936-1080 (US) MAKAROV, Alexey East Hanover New Jersey 07936-1080 (US)

(74)	Representative: Rudge, Sewkian
	Novartis Pharma AG Patent Department 4002 Basel 4002 Basel (CH)

(54)	IMMEDIATE RELEASE 4-METHYL-3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]-N-[5-(4-METHYL- 1H-IMIDAZOL-1-YL)-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE FORMULATION